Found 316 matching trials
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma PHASE1 The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation Disorders NA This study aims to evaluate the safety, feasibility, and preliminary effica...
Show More Location
Institute of Hematology & Blood Diseases Hospital, China
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases PHASE1 While glucocorticoids and immunosuppressants ameliorate manifestations of a...
Show More Location
Charité Universitätsmedizin Berlin
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant N/A The purpose of the study is to determine outcomes for Multiple Myeloma pati...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial PHASE2 Oral and intestinal mucositis are major risk factors for the occurrence of ...
Show More Location
Amsterdam UMC, location AMC
Learn More & Join Trial